2022
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management
Daniele S, Kim S, Grada A, Moore A, Suozzi K, Bunick C. Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management. American Journal Of Clinical Dermatology 2022, 24: 199-223. PMID: 36539678, DOI: 10.1007/s40257-022-00746-4.Peer-Reviewed Original ResearchConceptsTruncal acne vulgarisAcne vulgarisTruncal acneHalf of patientsFacial acne vulgarisSignificant psychosocial burdenAvailable treatment optionsCommon skin disorderTreatment guidelinesPsychosocial burdenTreatment optionsTruncal involvementPatient managementFacial lesionsClinical problemSkin disordersUpper armCosmetic approachSebaceous glandsCurrent MedicalSkin areasPatientsAcneFocused reviewFurther investigationRandom skin biopsies for diagnosis of intravascular large B-cell lymphoma: Retrospective analysis of 31 biopsies from a US dermatology inpatient consultative service with literature review
Kim SR, Ko CJ, Nelson CA, Ramachandran S, Gehlhausen JR. Random skin biopsies for diagnosis of intravascular large B-cell lymphoma: Retrospective analysis of 31 biopsies from a US dermatology inpatient consultative service with literature review. Journal Of The American Academy Of Dermatology 2022, 88: 714-716. PMID: 36152693, DOI: 10.1016/j.jaad.2022.09.016.Peer-Reviewed Original ResearchTreatment of traction alopecia with oral minoxidil
Kim R, Craiglow BG. Treatment of traction alopecia with oral minoxidil. JAAD Case Reports 2022, 23: 112-113. PMID: 35495975, PMCID: PMC9039860, DOI: 10.1016/j.jdcr.2022.03.023.Peer-Reviewed Original ResearchTender violaceous nodule on the palm
Jiang R, Kim R, Panse G, Zubek A. Tender violaceous nodule on the palm. JAAD Case Reports 2022, 24: 42-44. PMID: 35600570, PMCID: PMC9119823, DOI: 10.1016/j.jdcr.2022.01.039.Peer-Reviewed Case Reports and Technical Notes
2021
Subungual neuroma masquerading as green nail syndrome
Choi R, Kim R, Glusac EJ, Zubek A. Subungual neuroma masquerading as green nail syndrome. JAAD Case Reports 2021, 20: 17-19. PMID: 35024402, PMCID: PMC8728514, DOI: 10.1016/j.jdcr.2021.11.025.Peer-Reviewed Original ResearchClustered intraepidermal lymphocytes and Langerhans cell microgranulomas are consistently observed in hyperkeratotic palmoplantar eczema compared with palmoplantar psoriasis and mycosis fungoides palmaris et plantaris
Kim SR, McNiff JM, Ko CJ. Clustered intraepidermal lymphocytes and Langerhans cell microgranulomas are consistently observed in hyperkeratotic palmoplantar eczema compared with palmoplantar psoriasis and mycosis fungoides palmaris et plantaris. Journal Of The American Academy Of Dermatology 2021, 87: 884-886. PMID: 34883152, DOI: 10.1016/j.jaad.2021.11.057.Peer-Reviewed Original ResearchRepigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib
Kim R, Craiglow BG. Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib. JAAD Case Reports 2021, 16: 90-91. PMID: 34541274, PMCID: PMC8435988, DOI: 10.1016/j.jdcr.2021.07.021.Peer-Reviewed Original ResearchFunctional cooperativity between the trigger factor chaperone and the ClpXP proteolytic complex.
Rizzolo K, Yu AYH, Ologbenla A, Kim SR, Zhu H, Ishimori K, Thibault G, Leung E, Zhang YW, Teng M, Haniszewski M, Miah N, Phanse S, Minic Z, Lee S, Caballero JD, Babu M, Tsai FTF, Saio T, Houry WA. Functional cooperativity between the trigger factor chaperone and the ClpXP proteolytic complex. Nat Commun 2021, 12: 281. PMID: 33436616, DOI: 10.1038/s41467-020-20553-x.Peer-Reviewed Original Research
2020
Structural properties of target binding by profilaggrin A and B domains and other S100 fused-type calcium-binding proteins
Hinbest AJ, Kim SR, Eldirany SA, Lomakin IB, Watson J, Ho M, Bunick CG. Structural properties of target binding by profilaggrin A and B domains and other S100 fused-type calcium-binding proteins. Journal Of Dermatological Science 2020, 100: 39-49. PMID: 32893105, PMCID: PMC7752840, DOI: 10.1016/j.jdermsci.2020.08.009.Peer-Reviewed Original ResearchAmino Acid SequenceAnnexin A2Binding SitesCrystallography, X-RayFilaggrin ProteinsHumansHydrophobic and Hydrophilic InteractionsIntermediate Filament ProteinsIntermediate FilamentsKeratinocytesKeratinsMolecular Docking SimulationMutationProtein BindingProtein Conformation, alpha-HelicalProtein DomainsProtein PrecursorsRecombinant ProteinsS100 ProteinsScreening Novel Agent Combinations to Expedite CTCL Therapeutic Development
Mirza FN, Yumeen S, Lewis JM, King ALO, Kim S, Carlson KR, Umlauf S, Surovtseva YV, Foss FM, Girardi M. Screening Novel Agent Combinations to Expedite CTCL Therapeutic Development. Journal Of Investigative Dermatology 2020, 141: 217-221. PMID: 32534802, DOI: 10.1016/j.jid.2020.05.097.Peer-Reviewed Original ResearchJAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL
Yumeen S, Mirza FN, Lewis JM, King ALO, Kim SR, Carlson KR, Umlauf SR, Surovtseva YV, Foss FM, Girardi M. JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL. Blood Advances 2020, 4: 2213-2226. PMID: 32437546, PMCID: PMC7252559, DOI: 10.1182/bloodadvances.2020001756.Peer-Reviewed Original ResearchConceptsCutaneous T-cell lymphomaJAK inhibitionCTCL cellsMalignant cutaneous T-cell lymphomasAdvanced cutaneous T-cell lymphomaTreatment of CTCLAvailable systemic treatment optionsSkin-homing T lymphocytesSystemic treatment optionsT-cell lymphomaCTCL cell linesHistone deacetylase inhibitionGeneralized cytotoxic effectExpression of Bcl2Advanced diseaseSuch patientsPeripheral bloodTreatment optionsJAK/STAT pathwayT lymphocytesPreclinical assessmentTherapeutic targetStrong potentiationExtrinsic apoptosis pathwayDeacetylase inhibition
2019
IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
Ortolan LS, Kim S, Crotts S, Liu LY, Craiglow BG, Wambier C, Paschoal RS, King BA, Jabbari A. IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans. Journal Of Allergy And Clinical Immunology 2019, 144: 1731-1734.e1. PMID: 31470035, PMCID: PMC6900443, DOI: 10.1016/j.jaci.2019.08.014.Peer-Reviewed Original ResearchSegmental neurofibromatosis 1 with gonosomal mosaicism
Kim R, Kibbi N, Imaeda S. Segmental neurofibromatosis 1 with gonosomal mosaicism. International Journal Of Dermatology 2019, 58: e255-e256. PMID: 31286507, DOI: 10.1111/ijd.14586.Peer-Reviewed Case Reports and Technical NotesGuselkumab for the treatment of severe refractory psoriasis in a pediatric patient
Kim R, Kibbi N, Craiglow BG. Guselkumab for the treatment of severe refractory psoriasis in a pediatric patient. JAAD Case Reports 2019, 5: 552-554. PMID: 31245518, PMCID: PMC6581971, DOI: 10.1016/j.jdcr.2019.04.014.Peer-Reviewed Original Research
2018
BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
Kim R, Lewis JM, Cyrenne BM, Monico PF, Mirza FN, Carlson KR, Foss FM, Girardi M. BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition. Oncotarget 2018, 9: 29193-29207. PMID: 30018745, PMCID: PMC6044378, DOI: 10.18632/oncotarget.25670.Peer-Reviewed Original ResearchCutaneous T-cell lymphomaT-cell lymphomaCTCL cellsBCL2 inhibitionCell lymphomaAdvanced cutaneous T-cell lymphomaHDAC inhibitionSkin-homing T cellsPromising novel therapeutic strategyBET inhibitionNon-Hodgkin lymphomaPotential novel therapyCTCL cell linesDose-dependent decreaseNovel therapeutic strategiesHistone deacetylase inhibitionExtraterminal protein inhibitorSystemic therapyLymph nodesPeripheral bloodNovel therapiesT cellsTherapeutic strategiesCaspase-3/7 activationAdvanced stageTreatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
Kim R, Charos A, Damsky W, Heald P, Girardi M, King BA. Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib. JAAD Case Reports 2018, 4: 443-445. PMID: 29984277, PMCID: PMC6031588, DOI: 10.1016/j.jdcr.2017.12.003.Peer-Reviewed Original ResearchRapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy
Kim R, Heaton H, Liu LY, King BA. Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy. JAMA Dermatology 2018, 154: 370-371. PMID: 29387870, DOI: 10.1001/jamadermatol.2017.5778.Peer-Reviewed Original Research
2015
Adlayer-mediated antibody immobilization to stainless steel for potential application to endothelial progenitor cell capture.
Benvenuto P, Neves MA, Blaszykowski C, Romaschin A, Chung T, Kim SR, Thompson M. Adlayer-mediated antibody immobilization to stainless steel for potential application to endothelial progenitor cell capture. Langmuir 2015, 31: 5423-31. PMID: 25955536, DOI: 10.1021/acs.langmuir.5b00812.Peer-Reviewed Original Research